Holen Sie sich die Stockscreener-App
1.24
7.46%
-0.10
Vorhandelsmarkt:
1.24
Schlusskurs vom Vortag:
$1.34
Offen:
$1.33
24-Stunden-Volumen:
4.41M
Relative Volume:
0.97
Marktkapitalisierung:
$362.46M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-63.08M
KGV:
-4.5926
EPS:
-0.27
Netto-Cashflow:
$-72.53M
1W Leistung:
-10.14%
1M Leistung:
-22.50%
6M Leistung:
+76.51%
1J Leistung:
+29.42%
1-Tages-Spanne:
$1.20
$1.33
1-Wochen-Bereich:
$1.20
$1.42
52-Wochen-Spanne:
$0.515
$1.90
Ocugen Inc Stock (OCGN) Company Profile
Firmenname
Ocugen Inc
Sektor
Branche
Telefon
484-328-4701
Adresse
11 GREAT VALLEY PARKWAY, MALVERN, PA
Vergleichen Sie OCGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OCGN
Ocugen Inc
|
1.24 | 418.51M | 0 | -63.08M | -72.53M | -0.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.16B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
694.99 | 71.65B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.97 | 59.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
891.73 | 54.79B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
368.36 | 41.77B | 4.98B | 69.59M | 525.67M | 0.5197 |
Ocugen Inc Stock (OCGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-15 | Eingeleitet | Maxim Group | Buy |
| 2023-03-01 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2022-08-23 | Eingeleitet | Mizuho | Buy |
| 2022-06-15 | Fortgesetzt | ROTH Capital | Buy |
| 2022-06-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-07-26 | Eingeleitet | Noble Capital Markets | Outperform |
| 2021-06-11 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2021-05-07 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-02-09 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2021-02-04 | Hochstufung | H.C. Wainwright | Neutral → Buy |
Alle ansehen
Ocugen Inc Aktie (OCGN) Neueste Nachrichten
How Ocugen Inc. (2H51) stock compares with tech leadersRate Hike & Growth Oriented Trading Recommendations - newser.com
Key resistance and support levels for Ocugen Inc.July 2025 Chart Watch & Momentum Based Trading Ideas - newser.com
Is Ocugen Inc. showing signs of accumulationTrade Risk Assessment & Consistent Growth Equity Picks - newser.com
Is Ocugen Inc. stock resilient to inflationMarket Growth Summary & Fast Gain Swing Trade Alerts - newser.com
Price momentum metrics for Ocugen Inc. explainedWall Street Watch & Risk Managed Investment Signals - newser.com
Combining price and volume data for Ocugen Inc.Quarterly Trade Report & Fast Moving Stock Watchlists - newser.com
How high can Ocugen Inc. stock goJuly 2025 Macro Moves & Reliable Price Breakout Signals - newser.com
Is Ocugen Inc. still worth holding after the dipTrend Reversal & Weekly High Conviction Ideas - newser.com
Identifying reversal signals in Ocugen Inc.Weekly Stock Analysis & Community Verified Trade Signals - newser.com
Is Ocugen Inc. (2H51) stock a top dividend aristocrat candidateJuly 2025 Momentum & Free Expert Approved Momentum Trade Ideas - newser.com
Is Ocugen Inc. stock a safe investment in uncertain marketsWeekly Loss Report & Weekly High Return Forecasts - newser.com
Ocugen Advances Gene Therapy Pipeline as Phase 3 Trials Near Key Milestones - MyChesCo
Using economic indicators to assess Ocugen Inc. potentialPortfolio Return Summary & Low Risk Growth Stock Ideas - newser.com
Ocugen (OCGN) Is Down 7.0% After Mixed Q3 Results and Gene Therapy Milestones – What's Changed - simplywall.st
Ocugen (OCGN) Sees Higher Revenue but Wider Losses Is Funding the Pipeline a Growing Challenge? - Yahoo Finance
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on B - GuruFocus
How Ocugen Inc. (2H51) stock trades pre earningsRecession Risk & Real-Time Stock Price Movement Reports - newser.com
Will Ocugen Inc. stock outperform tech sector in 2025July 2025 Big Picture & Safe Entry Momentum Stock Tips - newser.com
Is it time to cut losses on Ocugen Inc.July 2025 Snapshot & Free Low Drawdown Momentum Trade Ideas - newser.com
Is Ocugen Inc. (2H51) stock resilient in recession scenariosSwing Trade & Risk Managed Investment Strategies - newser.com
Will Ocugen Inc. stock maintain dividend yieldFed Meeting & Target Return Focused Stock Picks - newser.com
Ocugen Reports Progress in Gene Therapy Trials Amid Financial Losses - MSN
Why Ocugen Inc. (2H51) stock trades below fair valueWeekly Gains Summary & Community Verified Swing Trade Signals - newser.com
Ocugen Inc (OCGN) Q3 2025 Earnings Call Highlights: Strategic Ad - GuruFocus
Ocugen Inc (OCGN) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - Yahoo Finance
Is Ocugen Inc. stock ready for breakoutDay Trade & Real-Time Market Trend Scan - newser.com
Finanzdaten der Ocugen Inc-Aktie (OCGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.35%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):